B2Z-24920-81899
3 vaccinations
3 coded responses
29 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 601 / IL
- Registered
- 2022-06-21
- Relationship
- Child or adolescent in my care
- Guardian
- 2RJ-13442-25044
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-16
Dose 1 — Pfizer-BioNTech
-
2022-06-21
Registered in v-safe
-
2022-06-21
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-06-22
- 2022-06-23
- 2022-06-30
-
2022-07-07
Dose 2 — Pfizer-BioNTech
- 2022-07-07
-
2022-07-08
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-07-09
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2022-07-10
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-07-11
- 2022-07-12
- 2022-07-13
- 2022-07-14
- 2022-07-21
- 2022-07-28
- 2022-08-04
-
2022-08-11
Survey response — day 35, dose 2, dependentMedDRA: Chills, Cough, Myalgia, Nausea, Oropharyngeal pain, Vomiting — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Muscle aches, chills, sore throat, cough, nausea, vomitingMedDRA releases: 2024-11 · check-in free text available
- 2022-08-19
-
2022-10-06
Survey response — 3 months, dose 2, dependentMedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2024-11 · check-in free text available
-
2022-12-29
Dose 3 — Pfizer-BioNTech
- 2023-01-01
- 2023-01-02
- 2023-01-03
- 2023-01-04
- 2023-01-05
- 2023-01-12
- 2023-01-19
-
2023-01-26
Survey response — day 28, dose 3, dependentMedDRA: Cough, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-02-02
- 2023-02-09
- 2023-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-16 | Pfizer-BioNTech | No |
| 2 | 2022-07-07 | Pfizer-BioNTech | No |
| 3 | 2022-12-29 | Pfizer-BioNTech | No |
Free text
Release 12 — day 35, dose 2, dependent
Symptoms: Muscle aches, chills, sore throat, cough, nausea, vomiting
Release 12 — 3 months, dose 2, dependent
Symptoms: Cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release